← Eichor
Condition: Small Cell Lung Carcinoma Sclc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Small Cell Lung Carcinoma Sclc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Can
Phase 3 · 49 location(s) · Dizal (Jiangsu) Pharmaceutical Co., Ltd. · NCT07182682EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER
NA · 1 location(s) · Medical University of Graz · NCT07267000Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04778839Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 · 40 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06625775Molecular Analysis and Treatment Options of SCLC
Phase N/A · 1 location(s) · Shanghai Chest Hospital · NCT05945745Standardization of a Platform of Preclinical Models Derived From NSCLC Patients
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT07629375Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Phase 1 · 29 location(s) · Novartis Pharmaceuticals · NCT06562192a Single-arm, Single-center, Open Clinical Study
Phase N/A · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT06431100Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Phase 2 · 3 location(s) · Alliance Foundation Trials, LLC. · NCT07149363Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carbo
Phase 2 · 34 location(s) · National Cancer Institute (NCI) · NCT05198830Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT02838836Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
Phase 3 · 1 location(s) · Tata Memorial Hospital · NCT05236946Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Phase 2 · 6 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06745882Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup
Phase N/A · 2 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT07441941Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell
Phase 1 · 2 location(s) · Centre Antoine Lacassagne · NCT03467360Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subje
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07175220TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
Phase 2 · 1 location(s) · TYK Medicines, Inc · NCT05948813Multiomics Tumor Evolution Model of NSCLC
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05352035Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06939127Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT06262386Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
Phase 2 · 3 location(s) · Hackensack Meridian Health · NCT05715229A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Phase 1/Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07535437A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small C
Phase 2 · 1 location(s) · Jiangsu Cancer Institute & Hospital · NCT07082179Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo
NA · 1 location(s) · Wen-zhao ZHONG · NCT07612722Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · 770 location(s) · Mirati Therapeutics Inc. · NCT04613596Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT04631770Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane
NA · 1 location(s) · Tang-Du Hospital · NCT06644066A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
Phase N/A · 3 location(s) · National Cancer Centre, Singapore · NCT06418412Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC
NA · 6 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07479277
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.